glp-1 drugs and parkinson's disease does not slow progression in phase 3 study GLP-1 Signalling as a Therapeutic

Isola JVV, Hense JD, Osrio CAP, Biswas S, Alberola-Ila J, Ocaas SR, Schneider A, Stout MB (2024) Reproductive ageing: inflammation, immune cells, and cellular senescence in the aging ovary

falciparum were cultured in cRPMI with a range of concentrations of compounds (up to 50M) for 72h

There is no oral or topical version of IGF-1 LR3 in research use

Other small case series or case reports noted potential benefits of NAC in DILI secondary to amiodarone [69], antibiotics [70], or dietary supplements [71]

The approach is always: comprehensive labs to identify whats actually driving the fog, then a targeted protocol to correct it